27 August 2018 : Clinical Research
MicroRNA-495 Confers Increased Sensitivity to Chemotherapeutic Agents in Gastric Cancer via the Mammalian Target of Rapamycin (mTOR) Signaling Pathway by Interacting with Human Epidermal Growth Factor Receptor 2 (ERBB2)
DOI: 10.12659/MSM.909458
Med Sci Monit 2018; 24: CLR5960-5972
HTML version available soon